• Erastin Reverses ABCB1-Mediated Docetaxel Resistance in Ovar

  2026-05-09

  This study demonstrates that Erastin, a well-characterized ferroptosis inducer, can overcome ABCB1-mediated multidrug resistance to docetaxel in ovarian cancer cells. By inhibiting ABCB1 drug efflux activity without altering protein expression, Erastin restores docetaxel sensitivity, suggesting a novel synergistic therapeutic approach for chemotherapy-resistant ovarian cancer.

• Syringin Targets EGFR/PI3K/Akt to Enhance Sunitinib in RCC C

  2026-05-08

  This study identifies Syringin as a promising bioactive natural product that inhibits renal cell carcinoma (RCC) cell proliferation, enhances apoptosis, and increases sensitivity to the RTK inhibitor sunitinib through modulation of the EGFR/PI3K/Akt signaling pathway. The findings provide mechanistic evidence for integrating natural product research with targeted therapy approaches to address sunitinib resistance in RCC.

• Polyethylenimine Linear (PEI, MW 40,000): Empowering Transla

  2026-05-08

  This thought-leadership article delves into the mechanistic and strategic frontiers of Polyethylenimine Linear (PEI, MW 40,000), reframing its role from a standard DNA transfection reagent to a pivotal enabler of translational research. Integrating mechanistic insights, competitive landscape analysis, real-world protocol parameters, and the latest evidence—including a bridge to recent advances in cardioprotective small molecule discovery—this piece offers actionable guidance for researchers aiming to scale from benchtop breakthroughs to clinical translation.

• Nadolol (SQ-11725): Pharmacokinetic Nuances and Assay Guidan

  2026-05-07

  Explore the advanced pharmacokinetic properties of Nadolol (SQ-11725) for hypertension research, including transporter-mediated dynamics and practical assay recommendations. This article uniquely bridges molecular transport insights with protocol optimization, delivering actionable value for scientific researchers.

• Cy3 NHS Ester (Non-Sulfonated): Technical Use Guide and QC

  2026-05-07

  Cy3 NHS ester (non-sulfonated) provides robust fluorescent labeling of amino groups in proteins, peptides, and oligonucleotides, excelling where high sensitivity in the orange spectral region is critical. It should not be used in workflows requiring entirely aqueous conditions or where protein integrity is compromised by organic co-solvents.

• LuQi Formula Attenuates Post-MI Remodeling via SPTLC2-Cerami

  2026-05-06

  This study demonstrates that the LuQi Formula (LQF) mitigates ventricular remodeling after myocardial infarction by downregulating SPTLC2-mediated de novo ceramide synthesis. The findings provide mechanistic insight into LQF’s cardioprotective effects and highlight the role of sphingolipid metabolism in cardiac pathology.

• Sulfaphenazole: Bridging Drug Metabolism and Vascular Repair

  2026-05-06

  Explore how Sulfaphenazole, a selective CYP2C9 inhibitor, empowers translational researchers to interrogate drug metabolism, vascular function, and antibacterial strategies—integrating mechanistic depth, evidence-based protocols, and a cross-domain outlook for precision biomedical research.

• Erastin (SKU B1524): Reliable Ferroptosis Inducer for Redox

  2026-05-05

  This article provides a scenario-driven, evidence-based guide for biomedical researchers utilizing Erastin (SKU B1524) as a selective ferroptosis inducer. It addresses common laboratory challenges in ferroptosis research, protocol optimization, and vendor selection, with rigorous support from recent literature and validated workflow recommendations.

• Thymosin-β4 Drives Angiogenesis via Notch/NF-κB in CLI Model

  2026-05-05

  Lv et al. demonstrate that thymosin-β4 (Tβ4) promotes angiogenesis in critical limb ischemia (CLI) mice by activating the Notch and NF-κB pathways. The study leverages genetic and pharmacological tools, including the IKK-1/IKK-2 inhibitor BMS-345541, to dissect pathway contributions, offering mechanistic clarity for researchers studying ischemic vascular disease.

• Cy3 Rabbit Anti-Goat IgG (H+L) Antibody: Technical Use Guide

  2026-05-04

  The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody enables sensitive, specific detection of goat IgG primaries in fluorescence-based immunoassays such as ICC/IF, IHC, flow cytometry, and ELISA. It should be used strictly within validated immunodetection workflows for goat antibodies and is not suitable for applications requiring cross-species reactivity or for non-immunoglobulin detection.

• Halo-seq Enables Spatially Resolved Subcellular Transcriptom

  2026-05-04

  The referenced study introduces Halo-seq, a light-activated RNA proximity labeling technique that achieves high-efficiency, spatially specific isolation of subcellular transcriptomes. This approach reveals new regulatory features of nuclear RNA export and offers a robust alternative to enzyme-mediated signal amplification for mapping RNA localization dynamics.

• HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus: Techni

  2026-05-03

  The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus provides a reproducible method for synthesizing Cy3-labeled RNA probes, addressing the need for high-yield, fluorescently detectable RNA in workflows such as in situ hybridization and Northern blotting. This kit is strictly for research applications and not suitable for diagnostic or clinical use.

• Reliable Biotin Detection with Streptavidin – Cy5 (SKU K1080

  2026-05-02

  This article explores real-world laboratory challenges in cell viability and proliferation assays, demonstrating how Streptavidin – Cy5 (SKU K1080) from APExBIO addresses reproducibility, sensitivity, and workflow efficiency. Scenario-based Q&As guide researchers through evidence-backed protocol decisions and vendor comparisons, supporting robust experimental outcomes.

• H3K18 Lactylation Drives NOD2-Linked Pyroptosis in Astrocyte

  2026-05-01

  Li et al. (2025) reveal that H3K18 lactylation in astrocytes, induced by unconjugated bilirubin, upregulates NOD2 and triggers pyroptosis via inflammatory signaling pathways. This work uncovers a novel epigenetic-metabolic link in bilirubin encephalopathy, providing new directions for therapeutic intervention.

• ALDOB K87 Lactylation Regulates Mitochondrial Fission in PH

  2026-05-01

  This study identifies ALDOB K87 lactylation as a key driver of mitochondrial fission and metabolic reprogramming in pulmonary hypertension (PH). By elucidating the lactate–ALDOB–DRP1 signaling axis in smooth muscle cells, the research advances our understanding of pathological vascular remodeling and highlights potential therapeutic targets.

16189 records 1/1080 page Next 12345 下5页 Last page